- Panaitescu AM, Wright D, Militello A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 35-37 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17419 pdf
- Wright D, Dragan I, Syngelaki A, Akolekar R, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound Obstet Gynecol 2017;49:194-200 pdf
- Litwinska M, Wright D, Efeturk T, Ceccacci I, Nicolaides KH. Proposed clinical management of pregnancies after combined screening for preeclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17418 pdf
- O' Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, Carbone IF, Dutemeyer V, Fiolna M, Frick A, Karagiotis N, Mastrodima S, de Paco Matallana C, Papaioannou G, Pazos A, Plasencia W, Nicolaides KH. Multicenter screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17455 pdf
- Neocleous A, Nicolaides K, Schizas C. Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset. IEEE J Biomed Health Inform DOI: 10.1109/JBHI.2016.2608859 pdf
- Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH. Impaired placentation in women with chronic hypertension that develop preeclampsia. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17517 pdf
- Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17484 pdf
- Santorum M, Wright D, Syngelaki A, Karagioti N, Nicolaides KH. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17283 pdf
- O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina FS, de Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides KH. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol DOI: 10.1002/uog.17399 pdf
- Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC. A study protocol for the prospective validation study: Screening programme for pre-eclampsia (SPREE). Ultrasound Obstet Gynecol DOI: 10.1002/uog.17467 pdf
- O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE). BMJ Open 2016;6:e011801 pdf
- Mastrodima S, Akolekar R, Yerlikaya G, Tzelepis T, Nicolaides KH. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks. Ultrasound Obstet Gynecol 2016;48:613-7 pdf
- Frick AP, Syngelaki A, Zheng M, Poon LC, Nicolaides KH. Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of pregnancy. Ultrasound Obstet Gynecol 2016;47:332-9 pdf
- Wright A, Guerra L, Pellegrino M, Wright D, Nicolaides KH. Maternal serum PAPP-A and free beta-hCG at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia. Ultrasound Obstet Gynecol 2016;47:762-7 pdf
- Sonek JD, Kagan KO, Nicolaides KH. Inverted Pyramid of Care. Clin Lab Med 2016;36:305-17 pdf
- Oliveira N, Poon LC, Nicolaides KH, Baschat AA. First trimester prediction of HELLP syndrome. Prenat Diagn 2016;36:29-33 pdf
- Frick AP, Nicolaides KH, Poon LC. Contingent Screening for Small by Weight for Gestational Age Neonates. Pediatr Endocrinol Rev 2016;13:568-73
- Wright D, Gallo DM, Gil Pugliese S, Casanova C, Nicolaides KH. Contingent screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol 2016;47:554-9 pdf
- O'Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol 2016;214:103.e1-103.e12 pdf
- Wright D, Silva M, Papadopoulos S, Wright A, Nicolaides KH. Serum pregnancy-associated plasma protein-A in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 2015;46:42-50 pdf